ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

INO Inovio Pharmaceuticals Inc New

10.38
0.255 (2.52%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Inovio Pharmaceuticals Inc New INO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.255 2.52% 10.38 08:53:51
Open Price Low Price High Price Close Price Previous Close
10.25 10.09 10.70 10.57 10.125
more quote information »

Recent News

Date Time Source Heading
16/4/202408:39PRNUSINOVIO Announces Pricing of Approximately $36 Million..
27/3/202409:28PRNUSINOVIO to Participate in The Citizens JMP Novel Therapeutics..
07/3/202408:05PRNUSINOVIO Reports Fourth Quarter and Full Year 2023 Financial..
06/3/202423:00PRNUSGeneos Therapeutics to Present New Clinical Data on..
06/3/202422:02IHMARKETNEWSU.S. Stock Futures Gain Ahead of Economic Insights; Oil..
22/2/202400:00PRNUSINOVIO to Report Fourth Quarter and Year-End 2023 Financial..
08/2/202403:46PRNUSINOVIO to Present at the Oppenheimer 34th Annual Healthcare..
03/2/202400:00PRNUSINOVIO Reports Inducement Grant Under Inducement Plan
01/2/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
27/1/202408:01EDGAR2Form S-3/A - Registration statement under Securities Act of..
26/1/202408:02EDGAR2Form 8-K - Current report
24/1/202400:00PRNUSINOVIO Announces Effective Date of 1-for-12 Reverse Stock..
23/1/202400:00PRNUSINOVIO to Participate in Virtual Fireside Chat on the..
13/1/202409:27EDGAR2Form 8-K - Current report
05/1/202400:00PRNUSINOVIO and Coherus Announce Clinical Collaboration to..
04/1/202400:00PRNUSINOVIO Plans to Submit a BLA for INO-3107 as a Potential..
29/11/202308:05EDGAR2Form DEF 14A - Other definitive proxy statements
18/11/202308:00EDGAR2Form PRE 14A - Other preliminary proxy statements
10/11/202308:35EDGAR2Form S-3 - Registration statement under Securities Act of..
10/11/202308:15EDGAR2Form 8-K - Current report
10/11/202308:05PRNUSINOVIO Reports Third Quarter 2023 Financial Results and..
10/11/202308:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202307:01EDGAR2Form 8-K - Current report
01/11/202323:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
26/10/202323:00PRNUSINOVIO to Report Third Quarter 2023 Financial Results on..
11/10/202307:00EDGAR2Form 8-K - Current report
11/10/202301:51DJNInovio Shares Rise 8% After FDA Feedback for INO-3107
10/10/202323:00PRNUSINOVIO Receives FDA Feedback that Data from Completed Phase..
28/9/202309:39PRNUSGeneos Therapeutics Closes its Series A3 Financing With..
07/9/202322:00PRNUSINOVIO Announces U.S. FDA Breakthrough Therapy Designation..
29/8/202322:00PRNUSINOVIO to Present at the H.C. Wainwright 25th Annual Global..
10/8/202306:23EDGAR2Form 8-K - Current report
10/8/202306:05PRNUSINOVIO Announces Second Quarter 2023 Financial Results and..
10/8/202306:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202322:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
01/8/202311:43EDGAR2Form 8-K - Current report
26/7/202323:32PRNUSINOVIO to Report Second Quarter 2023 Financial Results on..
08/7/202306:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
04/7/202307:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/6/202306:10GLOBEINOVIO Announces Notice of Pendency and Proposed Settlement..
01/6/202322:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
25/5/202322:00PRNUSINOVIO to Present at the 2023 Jefferies Healthcare..
24/5/202306:13PRNUSINOVIO Announces Orphan Drug Designation for INO-3107 for..
11/5/202306:05PRNUSINOVIO Reports First Quarter 2023 Financial Results and..
08/5/202322:00PRNUSNew Data from Phase 1/2 Trial of INO-3107 for the Treatment..
05/5/202322:00PRNUSINOVIO to Present at the 2023 RBC Capital Markets Global..

Your Recent History

Delayed Upgrade Clock